Registration and Pricing

The American College of Clinical Pharmacology^® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.

To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact INFO@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.

Requirements for Credits

All requirements for claiming CE credits are listed in the CE Info (Handout) tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated in their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits uploaded to the CPE Monitor.

CE Expiration 12/31/2027

2024 ACCP Virtual Journal Club Webinar: Estimation of Absolute and Relative Body Fat Content Using Noninvasive Surrogates: Can DXA Be Bypassed? 

Live Session: Wednesday, June 26^th, 2024, from 12:00 to 1:00 PM ET

On Demand: June 26^th, 2024 to June 26^th, 2027

Why is this article important to your practice? 

This study explores innovative methods to predict body fat content using easily measurable anthropometric variables like age, height, weight and waist circumference instead of relying on the expensive and less accessible dual-energy x-ray absorptiometry (DXA) scanning. This research is crucial as it provides an improved and validated algorithm for predicting absolute body fat, which can enhance clinical practices related to obesity management. Understanding these new predictive methods can directly impact practice, especially considering the critical role that body composition plays in pharmacokinetics and pharmacodynamics. Efficient and accurate body fat estimation methods are essential for optimizing drug dosing and therapeutic strategies in obese patients, thereby improving treatment outcomes and patient care. Learners that complete this activity will be provided an evidence-based, validated and predictive algorithm as an alternative to DXA scanning to accurately estimate absolute body fat.

Target Audience:

Interprofessional team of Physicians, Pharmacists, PhDs, Nurse Practitioners and other health care professionals who use the assessment of body fat content in clinical trials and clinical practice.

Learning Objectives

After completing this activity, the learner will be able to:

• Describe at least one limitation to the use of DXA scanning for obesity clinical trials and/or drug development;
• Identify at least one DXA-determined measurement that was selected as a dependent (outcome) variable in this study;
• List at least one surrogate variable that was predictive of DXA-determined absolute body fat;
• Identify which surrogate variable had the greatest impact (i.e., magnitude of change) on DXA-determined total body fat in men and women utilizing standardized regression coefficient data.

2024 ACCP STEP & ESP Webinar: Defining Your Journey: The Path to Professional Growth & Leadership

Live webinar: June 13, 2024 from 1:00 - 2:30 PM ET 

On-demand webinar recording: June 13, 2024 to June 13, 2027

Target Audience:

Student, Trainees & Early-stage Professionals interested in developing their leadership and professional growth as they transition into full-time careers.  

Learning Objectives

After completing this activity, the learner will be able to:

1. Identify key elements of effective leadership styles;

2. Practice interpersonal skills to achieve effective communication; 

3. Demonstrate how to inspire others to action to achieve common objectives;  

4. Employ resources and prioritize time to achieve milestones toward the stated objectives.

2024 ACCP STEP & ESP Webinar: Defining Your Journey: The Path to Professional Growth & Leadership

Live webinar: June 13, 2024 from 1:00 - 2:30 PM ET 

On-demand webinar recording: June 13, 2024 to June 13, 2027

Target Audience:

Student, Trainees & Early-stage Professionals interested in developing their leadership and professional growth as they transition into full-time careers.  

Learning Objectives

After completing this activity, the learner will be able to:

1. Identify key elements of effective leadership styles;

2. Practice interpersonal skills to achieve effective communication; 

3. Demonstrate how to inspire others to action to achieve common objectives;  

4. Employ resources and prioritize time to achieve milestones toward the stated objectives.

2024 ACCP Virtual Journal Club Webinar: Edoxaban Exposure in Patients with Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - On Demand

Live Session: Wednesday, March 20^th, 2024, from 2:00 to 3:00 PM ET

On Demand: March 20^th, 2024 to March 20^th, 2027

Why is this article important to your practice? 

There is a lack of clear understanding of high creatinine clearance on pharmacokinetic/pharmacodynamic (PK/PD) outcomes. Edoxaban 60 mg is approved for stroke prevention in patients with atrial fibrillation (AF) not fulfilling any dose-reduction criteria. As edoxaban is partially renally cleared (≈50%), it was postulated that edoxaban exposure may be lower in patients with high creatinine clearance (CrCL >100 mL/min); thus, efficacy could hypothetically be lower in this subpopulation. In this webinar, the author will discuss a prospective, randomized, double-blinded study comparing the pharmacokinetics, pharmacodynamics, efficacy and safety outcomes of edoxaban 60 mg once daily versus edoxaban 75 mg once daily in patients with CrCL exceeding 100 mL/min. The presentation will also illustrate the utility of population PK modeling to account for variability and estimate steady-state PK values based on the sparse PK concentrations collected in the study. 

Target Audience:

Interprofessional team of Physicians, Pharmacists, PhDs, and other health care professionals.

Learning Objectives

After completing this activity, the learner will be able to:

• Describe the impact of high creatinine clearance on edoxaban PK and PD and the potential clinical implications;
• Recognize the utility of population PK modeling in analyzing sparse PK concentrations collected from clinical studies;
• Describe the key elements of a prospective, randomized, placebo-controlled clinical trial.

Registration and Pricing

The American College of Clinical Pharmacology^® (ACCP) offers a monthly article from the The Journal of Clinical Pharmacology (JCP) for continuing education credit. See the CE Info tab for more information on credits. The ACCP JCP Journal CE articles are priced and packaged for January through December of the same calendar year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once registered, learners have access to all of the Journal CE articles for the calendar year as the articles are released.

To register, log into your ACCP online profile and then register by clicking the green Register button at the top right. Follow the online prompts to complete the registration process and to receive your registration confirmation. If you do not have an ACCP profile, one must be created before you can register for the Journal CE articles. If you do not know if you have a profile, please contact INFO@ACCP1.org for further information to avoid creating duplicate profiles. Please address all other questions to CE@ACCP1.org.

Requirements for Credits

All requirements for claiming CE credits are listed in the CE Info (Handout) tab. Continuing education credits and certificates must be claimed within 30-days of completing the monthly article offering. Continuing Pharmacy Education (CPE) data is uploaded into the CPE Monitor at the end of each month. The pharmacist's NABP# and MMDD of birth must be updated into their ACCP Profile or emailed to CE@ACCP1.org in order to have CPE credits uploaded to the CPE Monitor.

CE Expiration 12/31/2026

2023 ACCP Webinar: From Exogenous Probes to Endogenous Biomarkers: A Paradigm Shift in the Approach to Assess Transporter Mediated Drug-Drug Interactions - ON DEMAND

Why is this Webinar important to you?

Membrane bound drug transporters, expressed in various tissues throughout the body, control the movement of endogenous and exogenous substances in and out of cells at various sites in the body.  Some drugs interact with transporters either as substrates or modulators (inhibitors or inducers), therefore, evaluation of transporter mediated drug-drug interactions (DDI) during drug development and post-approval is important to formulate clinical management strategies and ensure the safe and effective use of concomitantly administered drugs.  

 An integral part of a comprehensive clinical pharmacology program includes assessing the effect of an investigational drug on various transporters.  This assessment may be completed by either conducting several DDI trials (generally a trial for each transporter modulated by the investigational drug) or by conducting one trial to explore the effect of the investigational drug on the pharmacokinetics of several simultaneously administered (at therapeutic dose or microdose) probe drugs (“probe cocktail” approach). 

 More recently, the idea of assessing changes in the concentration of endogenous biomarkers (which are substrates of clinically relevant transporters) to gain insight on the potential of a drug to inhibit transporter activity has received widespread attention. Numerous publications and presentations by various investigators have highlighted how endogenous biomarkers can enable early “derisking” by assessing DDI potential over a wide range of inhibitor exposures, facilitate quantitative prediction of DDIs and provide mechanistic insights into observed DDIs. 

Target Audience

Physicians, Pharmacists, PhDs and other healthcare professionals interested in the evaluation of transporter-mediated DDIs during drug development and post-approval.

Learning Objectives

After completing this activity, the learner will be able to:

1. Learn how the transporter only probe cocktail trial approach has been used in drug development;
2. Explain the advantages and challenges of using microdose trials for assessment of transporter-mediated DDIs;
3. Describe the emerging role of endogenous biomarkers in the assessment of transporter-mediated DDIs;
4. Discuss how the assessment of endogenous biomarkers can be integrated in probe cocktail trials for comprehensive characterization of transporter-mediated DDI assessments.

2023 ACCP Student, Trainee & Early-stage Professional Webinar: "Delivering an Effective Interview Presentation" | ON DEMAND

On Demand: October 25th, 2023 to October 25th, 2026

Target Audience:

This webinar will be important to physicians, pharmacists, PhDs and other (students, trainees & early-stage professionals) seeking guidance and valuable insights on how to present an impactful scientific presentation and be well prepared for a robust Q&A as part of an interview process.

Learning Objective:

After completing this activity, the learner will be able to:

1. Discuss approaches for creating clear and concise presentation targets for the hiring audience and target position;
2. Learn and understand key strategies to engage and retain the target audience's interest;
3. Develop skills to approach Q&A sessions with confidence.

2023 ACCP Student, Trainee & Early-stage Professional Webinar: "Key Expertise/Insight to Ace the Interview" | ON DEMAND

On Demand webinar: October 11th, 2023 to October 11th, 2026 

Target Audience:

This webinar will be important to physicians, pharmacists, PhDs and other (students, trainees & early-stage professionals) seeking guidance and valuable insights on how to prepare for  and ace an interview to get the job you want!

Learning Objective:

After completing this activity, the learner will be able to:

1. Navigate etiquette expectations throughout introductions and the interview process;
2. Identify appropriate and inappropriate behaviors during the virtual and on-site job interview;
3. Formulate directed and meaningful questions and answers during the interview process.

2023 ACCP Student, Trainee & Early-stage Professional Webinar: "Crafting a High Impact CV" | ON DEMAND

On Demand: September 20th, 2023 to September 20th, 2026

Target Audience:

This webinar will be important to physicians, pharmacists, PhDs and other (students, trainees & early-stage professionals) seeking guidance and valuable insights on developing a high-quality, impactful CV that will get the attention of  HR and the hiring managers.

Learning Objective:

After completing this activity, the learner will be able to:

1. Discuss the employer's perspectives on the screening and hiring process;
2. Identify ways to develop and feature unique skills and experiences in a high impact CV based on targeted career goals;
3. Utilize professional and social platforms effectively.